Feb 21, 2018 - Should You Follow Seth Klarman and David Tepper Into Allergan?, Stocks: AGN, Seth Klarman, David Tepper, Wallace Weitz, release date:Feb 21, 2018
Feb 21, 2018 - Muhlenkamp & Co. 4th Quarter 2017 Shareholder Letter, Stocks: AAPL,ON,OLED,TEVA,SAVE,AGN, release date:Feb 20, 2018
Feb 21, 2018 - David Tepper’s 13F portfolio value increased from $7.12B to $10.73B this quarter.Micron Technology is the largest individual stock position at ~11% of the portfolio.Appaloosa increased Micron Technolo
Feb 21, 2018 - Teva (TEVA) faces significant challenges including rapid erosion in sales of Copaxone and pricing erosion in the U.S. generics business.
Feb 20, 2018 - Neurocrine's deliberate approach to pipeline development could lead to four drugs and six indications commercialized over the next four to five years, with multiple $1 billion-plus opportunities. Ingr
Feb 20, 2018 - John Paulson’s 13F portfolio value decreased from $5.57B to $5.12B this quarter.Paulson & Company's largest three positions are SPDR Gold ETF, Mylan NV, and Shire plc.Paulson increased Horizon Pharmac
Feb 19, 2018 - Seth Klarman Buys Time Warner, Boosts Pioneer, Allergan, Stocks: TWX,PXD,AGN,CAH,MCK,QRVO,ABC,FOXA, Seth Klarman, release date:Feb 19, 2018
Feb 19, 2018 - Berkshire Hathaway has made an investment in Teva for $358 million, but that doesn't fix any of the company's issues at hand.Earnings have continued to decline year over year, despite Teva's attempt t
Feb 16, 2018 - Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2017, Stocks: AGN, release date:Feb 16, 2018
Feb 16, 2018 - Ironwood Pharmaceuticals (IRWD) beats estimates on both counts in the fourth quarter. Demand for Linzess continues to rise.